Topical glycopyrronium tosylate (DRM04) for the treatment of primary axillary hyperhidrosis: Pooled results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials
2018 ◽
Vol 79
(3)
◽
pp. AB298
Keyword(s):
Phase 3
◽
2019 ◽
Vol 81
(4)
◽
pp. AB217
2018 ◽
Vol 79
(3)
◽
pp. AB147
2018 ◽
Vol 20
(1)
◽
pp. 135-145
◽
2018 ◽
Vol 79
(2)
◽
pp. 287-293
◽